Gelonghui, August 28th | Anhui Fengyuan Pharmaceutical (000153.SZ) released the 2024 interim report, with a total operating income of 2.308 billion yuan during the reporting period, a year-on-year increase of 0.98%; the net profit attributable to the shareholders of the listed company was 0.1 billion yuan, a year-on-year decrease of 2.72%; the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 85.6384 million yuan, a year-on-year decrease of 2.71%; the basic earnings per share were 0.2156 yuan.
丰原药业(000153.SZ：上半年净利润1.00亿元，同比下降2.72%
Anhui Fengyuan Pharmaceutical (000153.SZ: net income of 0.1 billion yuan in the first half of the year, a year-on-year decrease of 2.72%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.